Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Non-Current Liabilities (2020 - 2025)

Agilon Health's Total Non-Current Liabilities history spans 6 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 7.98% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 7.98%, while the annual FY2025 figure was $1.1 billion, 7.98% down from the prior year.
  • Total Non-Current Liabilities reached $1.1 billion in Q4 2025 per AGL's latest filing, down from $1.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.6 billion in Q1 2024 to a low of $486.0 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: soared 116.46% in 2023, then fell 14.14% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $486.0 million in 2021, then increased by 18.19% to $574.4 million in 2022, then soared by 75.75% to $1.0 billion in 2023, then grew by 17.58% to $1.2 billion in 2024, then dropped by 7.98% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Total Non-Current Liabilities are $1.1 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).